Genmab (CPSE:GMAB) Valuation Check After Mixed Recent Share Performance [Yahoo! Finance]
Genmab A/S - American Depositary Shares (GMAB)
Company Research
Source: Yahoo! Finance
Genmab (CPSE:GMAB) has drawn investor attention after a month return of about 10%, alongside a past 3 months decline near 10% and a near 40% total return over the past year. See our latest analysis for Genmab. That mix of a 10.2% 1 month share price return, a 9.7% 3 month share price decline, and a 39.7% 1 year total shareholder return suggests near term enthusiasm building on a stronger longer term recovery in investor sentiment. If you are weighing Genmab against other healthcare names, this is a good moment to see which companies are catching attention in the 129 healthcare AI stocks With Genmab trading at DKK 1,804 and an analyst price target of DKK 2,233.74, alongside a value score of 3 and a quoted intrinsic discount, the key question is whether this represents a genuine opportunity or if the market already prices in future growth. Most Popular Narrative: 19.2% Undervalued Genmab's most followed narrative sets a fair value of DKK 2,233 per share, which sits well abo
Show less
Read more
Impact Snapshot
Event Time:
GMAB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GMAB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GMAB alerts
High impacting Genmab A/S - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
GMAB
News
- Major Shareholder AnnouncementGlobeNewswire
- Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2026GlobeNewswire
- Genmab Presents the Safety and Tolerability of Rinatabart Sesutecan (Rina-S®) in Combination with Bevacizumab in Advanced Ovarian CancerBusiness Wire
- Genmab: Multiple Binaries Could Alter The Thesis [Seeking Alpha]Seeking Alpha
- Major Shareholder AnnouncementGlobeNewswire